Introduction
Antimicrobial resistance (AMR) is a global public health threat with antimicrobial use in humans significantly contributing. [1] [2] [3] Approximately 80% of UK antimicrobial use is in the community, with up to 50% deemed inappropriate. 1 Associations between primary care prescribing and AMR are well described, 1, [4] [5] [6] [7] and multiple initiatives have targeted reductions in this prescribing, 2, 3, [8] [9] [10] but UK rates still appeared to be increasing until 2012. 11, 12 This interpretation is based on population-level volumes of antimicrobials dispensed, measured in WHO Collaborating Centre for Drug Statistics Methodology's DDD. 13 DDD is the assumed average maintenance dose per day for an individual drug's main indication in adults rather than the actual daily dose used in practice, which has changed over time, as has the mix of antimicrobials used, which also affects total DDD. 13 Increases in total DDD could be due to more people being prescribed, more prescriptions for each person, and/or changes in antimicrobial choice or dose. Therefore, total DDD can change without changes in the proportion of the population exposed. Measures other than total DDD are required to examine antimicrobial use and the impact of antimicrobial stewardship interventions, 14 and changes within specific patient groups and antimicrobials could help explain population changes. In this study, we examined changes in primary care antimicrobial use from 1995 to 2014 in Tayside, Scotland, using patient-level data for all community dispensed antimicrobials across a complete geographical population.
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Population and methods
The Tayside region of Scotland has a stable population with healthcare delivered by a single NHS organization. Access to NHS services requires registration with a single general practice that delivers all primary healthcare including prescribing.
The Health Informatics Centre (HIC), 15 University of Dundee, enables anonymized linkage of health and demographic data from multiple population datasets in NHS Tayside at the individual patient level, via a unique identifier (the community health index number) used across all healthcare delivery in Scotland. We linked demographic data on everyone registered with a Tayside general practice to dispensed primary care prescriptions for oral antimicrobials for financial years 1995, 2000 and 2005-14. Annual measurements were in financial years (e.g. 2005 is 1 April 2005-31 March 2006) so each year included a complete winter. HIC provided annual population estimates by age and gender. We calculated the DDD for each prescription using 2014 values.
13 Data allowing DDD calculation (either/both of strength or quantity) were missing from 0.8% of prescriptions (highest in earlier years) so we used multiple imputation to estimate missing DDD values, with age, gender, drug and year of prescription as predictors. Antimicrobials were grouped into classes as defined in the British National Formulary version 68 chapter 5 (penicillins, tetracyclines, macrolides, sulphonamides and trimethoprim, quinolones, metronidazole and tinidazole, cephalosporins, other). 16 We calculated antimicrobial DDD and prescriptions dispensed per 1000 population per year, in total, by class and by age group (,5 years old, 5-64 years old, .64 years old). We then calculated the proportion of the population with at least one prescription in each study year, the mean and median number of prescriptions per patient per year among patients with any antimicrobial prescription in that year, and the mean and median DDD per prescription in each year, in total and by age group and gender. Statistical comparisons between 2014 and 1995 used v 2 tests for proportions, Student's t-test for means and Mann-Whitney U-test for medians. Statistical tests of trend for total DDD and total prescriptions, both per 1000 population per year, included the continuous data period . The large dataset means that the statistical tests of significance should be interpreted alongside clinical significance.
To estimate the extent to which changes in total DDD and total prescriptions, per 1000 population, were attributable to changes in each contributory measure (patients per 1000 population with any prescription, mean prescriptions per patient with any, mean DDD per prescription) we calculated the relative (percentage) change in each measure for each year compared with 1995.
To investigate potential reasons behind any changes we first examined seasonal variation in prescribing, which is attributed to prescribing for respiratory tract infection. Seasonal variation, using DDD, is a European Surveillance of Antimicrobial Consumption quality indicator. 17, 18 We calculated prescriptions per 1000 population quarterly by age group and expressed seasonal variation as overuse in 'winter' quarters (October-March) compared with the previous 'summer' quarters (April-September) as a percentage, and compared 2014 to 1995 using v 2 tests. We then examined trends in prescribing from 2005 to 2014, of 12 commonly prescribed individual antimicrobial drugs (amoxicillin, ciprofloxacin, clarithromycin, co-amoxiclav, doxycycline, erythromycin, flucloxacillin, lymecycline, nitrofurantoin, oxytetracycline, penicillin V and trimethoprim). Anonymized record linkage was conducted in accordance with HIC standard operating procedures. 15 These are approved by the East of Scotland Research Ethics Service and the NHS Tayside Caldicott Guardian with agreement that studies adhering to the standard operating procedures do not require individual ethical review. All data were analysed in IBM SPSS statistics v22 in an ISO27001 and Scottish Government accredited data Safe Haven.
Results
In 1995 and 2014, there were 419447 and 441298 registered patients, respectively; 49% were male. In all study years, 5% were ,5 years old, but the proportion .64 years increased from 16% to 20%. In 1995, 2377258 antimicrobial DDD were dispensed, rising to 3083451 in 2014, but prescriptions fell from 345328 to 294391, and the proportion of the population exposed fell from 39% to 31%.
DDD per 1000 population
Among the whole population, DDD per 1000 population fell between 1995 and 2000 then increased to a peak at 7092 in 2011 before decreasing to 6987 in 2014 (Table 1, Figure 1 ). There was a very large (68%) reduction among those ,5 years but increases otherwise (Table 1) . Change varied by antimicrobial class (Figure 1) , with more than doubling of tetracycline DDD per 1000 population per year between 1995 and 2014 (18% versus 31% of total DDD), and increases in all other classes except cephalosporins (7% versus 0.5%) and quinolones (4% versus 2%) ( Figure 1 and Table S1 , available as Supplementary data at JAC Online).
Prescriptions per 1000 population
Antimicrobial prescriptions per 1000 population overall fell between 1995 and 2000 then increased until 2011 before falling to 667 by 2014 (Table 1, Figure 2 ). There was a large (61%) reduction among those ,5 years and a small (2%) increase among those .64 years (Table 1) . Seasonal variation was greatest among preschool children (Figure 3 ) with 52%-69% more prescriptions per 1000 population each winter, except in 2007 (40%) due to low winter prescribing, and no significant difference between 1995 and 2014 (v 2 test P " 0.92). Seasonal variation in other age groups decreased over time, from 29% among 5-64 year olds and 25% among those .64 years old in 1995, to 5% and 6% in 2014, respectively (v 2 tests P , 0.001). Changes by antimicrobial class were similar to DDD, with reductions in cephalosporins (from 9% to 1% of prescriptions) and quinolones (from 4% to 2%), and increases in tetracyclines (10%-17%) and sulphonamides/trimethoprim (7%-12%) ( Figure 2 , Table S1 ).
Proportion prescribed any antimicrobial
The proportion of the population with at least one antimicrobial prescription per year fell overall. There was a reduction from 1995 to 2000, followed by increases between 2005 and 2012, then a reduction to 308 per 1000 population by 2014 (Tables 1 and 2 ). The biggest reductions were among those ,5 years old, who had the highest rate until 2005. Older people had the highest rate after that, but this reduced from 445 to 412 per 1000 population between 2010 and 2014. Among 5-64 year olds, there was a 24% reduction overall (Table 1 ). Higher proportions of females (11%-13% difference) had prescriptions each year but without temporal trend in differences (45% versus 33% in 1995; 37% versus 25% in 2014). Gender difference was largest among 5-64 year olds (females 13%-15% higher each year). Among those ,5 years old more males (1-3% higher each year) had any prescription (Table S2) .
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Prescriptions per patient dispensed at least one antimicrobial
In 1995, the 164864 people in Tayside with at least one antimicrobial prescription had a mean 2.09 prescriptions. Overall, there were clinically small but statistically significant changes over time, with increases since 2000 resulting in patients with any prescription in 2014 receiving a mean additional 0.08 prescriptions compared with 1995. There were reductions among preschool children and increases among older people (Table 1) . Females with any prescription had higher mean prescriptions, overall (mean additional 0.19-0.28 prescriptions per patient per year), among 5-64 year olds (additional 0.20-0.28) and those .64 years (additional 0.15-0.36), but among those ,5 this was higher for males (additional 0.00-0.12). The gender difference among those .65 increased over time but there were no other temporal patterns (Table S2) .
Median prescriptions per patient with any per year was 1.00 except among those .64, and those ,5 in 1995 only, with median 2.00 (Table 1) .
DDD per prescription
Mean DDD per prescription overall increased by more than half over the study period (Tables 1 and 2 ). Among young children it 
Contribution to changes in aggregate measures
Total antimicrobial DDD per 1000 population was 24% higher in 2014 than in 1995 despite prescriptions per 1000 population decreasing by 19% (Table 2) . Of potentially contributory Neilly et al.
measures, the proportion of the population with any prescription fell continuously and although mean prescriptions per patient increased until 2011, the changes are numerically small and decreased slightly by 2014 (Table 2) . Changes in this measure only account for 10455 (3.6%) prescriptions dispensed in 2014. In contrast, the mean DDD per prescription increased by 52.2% between 1995 and 2014 ( Table 2) . Had the mean DDD per prescription not changed, total DDD in 2014 would have been 2025410 (rather than the observed 3083451), a 19% reduction in DDD per 1000 population from 1995, rather than the observed 24% increase.
Trends in individual drugs
Amoxicillin had the highest DDD and prescriptions per 1000 population of any individual drug and both increased until 2011 then fell until 2014 ( Figure 4 and Table S3 ). The converging trend lines for DDD and prescriptions per 1000 population reflect the increasing DDD per prescription (Figure 4 ). Other penicillins (co-amoxiclav, flucloxacillin and penicillin V) also had increasing DDD per prescription, and reducing prescriptions per 1000 population (Figure 4) . Drugs targeted by a 2008 Tayside antimicrobial stewardship intervention (ciprofloxacin and co-amoxiclav) 19 had reducing DDD and prescriptions per 1000 population since 2008, while drugs recommended in the intervention guidelines (doxycycline, nitrofurantoin and trimethoprim) 19 had increasing DDD and prescriptions per 1000 population but reducing DDD per prescription (Figure 4 ). Clarithromycin and erythromycin had high mean DDD per prescription, with small increases over time (Figure 4 ). Lymecycline and oxytetracycline have very high mean DDD per prescription (.28 at each time point; Figure 4) , reflecting long-term use for acne, and resulting in disproportionate contributions to total DDD per 1000 population for a relatively small number of patients ( Figure 4 and Table S3 ). (4) 2006 (1) 2006 (2) 2006 (3) 2006 (4) 2007 (1) 2007 (2) 2007 (3) 2007 (4) 2008 (1) 2008 (2) 2008 (3) 2008 (4) 2009 (1) 2009 (2) 2009 (3) 2009 (4) 2010 (1) 2010 (2) 2010 (3) 2010 (4) 2011 (1) 2011 (2) 2011 (3) 2011 (4) 2012 (1) 2012 (2) 2012 (3) 2012 (4) 2013 (1) 2013 (2) 2013 (3) 2013 (4) 2014 (1) 2014 (2) 2014 (3) 2014 (4) 2015 ( Antimicrobial use: trends and measures
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Discussion
Summary
In this large population-based study with individual prescribing data we found that antimicrobial use in DDD increased considerably between 1995 and 2014 in Tayside, despite substantial reductions in prescriptions per 1000 residents and the proportion of the population exposed. Between 2000 and 2011 there were annual increases in total prescriptions, the proportion of the population exposed, and mean prescriptions per patient, but total prescriptions and the proportion exposed then fell again and had returned to the same level as 2000, or lower, by 2014. Among preschool children (,5 years old) antimicrobial use by all measures decreased substantially, but among older people (.64 years old) all measures were the same or higher, except the proportion exposed, which had decreased by 7%. Seasonal variation, representing prescribing for respiratory tract infection, reduced overall but remained high among preschool children. The most significant change in prescribing practice was the large increase in mean DDD per prescription, which was driven by both increasing Neilly et al.
doses (e.g. penicillins and macrolides) and changes in choice of antimicrobial (e.g. greater use of doxycycline).
Strengths and limitations
We report secular trends across a comprehensive set of antimicrobial prescribing measures using patient-level dispensed prescribing data across a whole geographical population. Most previous reports generally focus on volume (e.g. DDD) and/or prescriptions (or packages) per 1000 population, or patient-level analysis for specific clinical conditions. [20] [21] [22] [23] [24] [25] [26] A recent, more comprehensive, study included data across a whole country but without demographic information and included data for only 7 years.
14 Our ability to link demographic and detailed prescribing data at patient level, including historically, enabled detailed investigation over a relatively long period.
The limitations of this study include those common to observational studies using routine data, such as potentially incomplete data. We addressed missing DDD data using multiple imputations. Consistent with successful imputation, the mean DDD per prescription was almost identical afterwards. A further limitation is the lack of prescribing indication data, but coding in GP records is not reliably consistent between practices or over time. In our analysis of 12 individual drugs, prescriptions per 1000 population of trimethoprim and nitrofurantoin, both used almost exclusively for urinary tract infections in NHS Tayside, increased after a stewardship intervention that promoted these drugs, 19 then levelled off after 2011 (Figure 4) . The decreasing mean DDD per prescription is consistent with recommended short-course treatment for Antimicrobial use: trends and measures JAC uncomplicated urinary tract infections. 27 The proportion of nitrofurantoin and trimethoprim prescriptions for women aged 16-64 years for 3 days (0.6 g nitrofurantoin, 1.2 g trimethoprim), increased from 0.5% to 31.5%, and 13.1% to 59.9%, respectively, between 1995 and 2014. Reductions in trends of amoxicillin and doxycycline prescriptions since 2011/2012, without increases in other drugs used for respiratory tract infections (Figure 4) , suggest reductions in prescribing for this indication recently.
While we cannot assume similar changes in patient-level prescribing explain trends in DDD elsewhere, the observed reductions in cephalosporin and fluoroquinolone use and increases in tetracycline use are consistent with national guideline changes, 19, 28 and we know that cephalosporins, co-amoxiclav and fluoroquinolones, as a proportion of all community prescriptions, have reduced across Scotland and in England. 12, 29 These intended changes contributed to observed increases in DDD due to promoted drugs such as doxycycline having a relatively low DDD value. Changes in recommended dosing additionally contributed to the observed increased DDD per prescription. Local guideline recommended amoxicillin doses for non-severe community acquired pneumonia increased from 500 mg to 1 g three times daily in 2009, 28, 30 and the increasing amoxicillin DDD per prescription is consistent with this guideline influencing dosing. Similar trends in dosing impacting on DDD per treatment have occurred elsewhere, 14 indicating our findings will apply more widely.
Comparison with other data
The observed increase in total antimicrobial DDD until 2011 is consistent with other reports of primary care antimicrobial use, 11, 14, [31] [32] [33] [34] with many developed countries reporting reductions in the 1990s and increases between 2000 and 2010. 9, 12, 23, 35 Compared with primary care data from all Scotland and from England, Tayside 40 National reports have limited adjustment for population demographics but an exception is the specific therapeutic group age-sex weightings related prescribing units (STAR-PU) English prescribing indicator, 29 which provides useful adjusted trends over time but has limited external comparison.
Two large European studies analysing antimicrobial prescribing data up to 2007, reported different trends when measuring using DDD versus packages per 1000 population, 22, 23 and one reported rising DDD per package (0.04-0.31 DDD increase/package/year), similar to our findings. 22 A Belgian study reported increases in antimicrobial DDD but decreases in antimicrobial packages, treatments and the proportion of people exposed from 2002 to 2009 using a variety of measure definitions (rates per 1000 population, per 1000 insured patients, per 1000 GP contacts).
14 None of these studies reported prescribing measures by age or gender of patients exposed, or for individual antimicrobial drugs, which we found help explain trends in the overall measures.
Between 1994 and 2000, reductions of 45% in the proportion of patients with respiratory tract infections prescribed antimicrobials, and 27% in total prescriptions per 1000 registered patients, were reported across 108 UK general practices. 20 Similarly, reductions in total antimicrobial prescriptions and prescriptions for upper respiratory tract infection, adjusted for patient, practitioner and comorbidity, per 100 patient encounters, were reported between 1991 and 2003 across 495 Australian GPs. 26 In contrast, across 570 UK general practices, a 29% increase in the proportion of cough/cold consultations with an antimicrobial prescription was observed between 1995 and 2011. 24 Consultations coded as cough/cold increased and the authors attributed betweenpractice variation to varying concordance with antimicrobial stewardship, 24 but this could be due to coding.
Implications
Our results demonstrate that the main factor influencing total antimicrobial DDD in Tayside is DDD per prescription. Total volume in DDD does not reliably represent actual antimicrobial use so prescriptions/packages per 1000 population and the proportion of the population exposed better evaluate changes over time and the impact of stewardship interventions. What this means for the impact on emerging AMR is not clear, but a recent study modelling relationships between use and resistance found different associations if use was measured in DDD versus packages. 21 However, following reductions in antimicrobial use in all age groups between 1995 and 2000, we observed increases in most measures between 2000 and 2011, with the exception of preschool children. In the last few years of observation there were reductions across several measures, but achieving substantial and sustained reductions in the proportion of the population exposed remains challenging for antimicrobial stewardship globally. 9 National and local antimicrobial stewardship activity in Scotland, particularly since the formation of the Scottish Antimicrobial Prescribing Group in 2008, has led to changes in choice of antimicrobials ( Figures 1, 2 and 4) 9,12,19 but there is less impact on total prescribing within our study timeframe. Older people appear an obvious target group for stewardship due to high rates of exposure and higher risk of adverse events, e.g. Clostridium difficile infection. 41 However, for lower respiratory tract infections, the number needed to treat to prevent serious complications is lower in older people, 42 making reductions challenging. Prescribing rates are lower among those aged 5-64 years but they received 62% of all antimicrobial prescriptions in Tayside in 2014. They may be a better target for stewardship, with greater scope for change. Recent data from .600 general practices found minor increases in treatable respiratory tract infections associated with large reductions in antimicrobial prescribing, but the authors acknowledged the need for analysis in high-risk subgroups. 43 
Conclusions
Our findings highlight the importance of studying trends in antimicrobial use in greater detail than total volume in DDD. With antimicrobial stewardship focusing on reducing total prescribing, we need to replicate the large reductions observed in the 1990s, building on the small reductions since 2011, and to learn from continued reductions among preschool children. Further research is required to understand better the relationship between antimicrobial consumption and resistance and the relative importance of individual and community exposure.
